Dr. Marty Makary, head of the FDA, is resigning after a rocky tenure. His leadership faced widespread complaints from various political and industry groups, and he struggled with bureaucracy and political interference, notably from Health Secretary Robert F. Kennedy Jr., leading to concerns about scientific principles being overridden.
Dr. Marty Makary, the commissioner of the Food and Drug Administration, is resigning from his post following a tumultuous tenure. His leadership drew significant complaints from a diverse array of groups, including health industry executives, anti-abortion activists, vaping lobbyists, and other allies of President Donald Trump. Makary, a surgeon and health researcher, gained prominence among Republicans for his outspoken criticism of COVID-19 health measures and frequent appearances on Fox News. However, he struggled to effectively manage the FDA’s complex bureaucracy and failed to secure the confidence of its staff, particularly after mass layoffs and leadership reshuffles. His time at the helm was marked by several controversies where the agency's scientific principles appeared to be compromised by political interests, including those of Health Secretary Robert F. Kennedy Jr. As the leader of an agency regulating billions in consumer goods and medicines, Makary faced the unique challenge of balancing calls from Trump and other Republicans to cut red tape with Kennedy’s intense scrutiny of the safety of vaccines, drugs, and food additives.
